miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients.
about
Role of microRNAs in chemoresistanceNon-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer MetabolismAdaptive responses of androgen receptor signaling in castration-resistant prostate cancerUncovering the roles of miRNAs and their relationship with androgen receptor in prostate cancerPrognostic role of microRNA-205 in multiple human malignant neoplasms: a meta-analysis of 17 studiesMicroRNA as new tools for prostate cancer risk assessment and therapeutic intervention: results from clinical data set and patients' samplesNoncoding RNAs as novel biomarkers in prostate cancer.miR-205 is frequently downregulated in prostate cancer and acts as a tumor suppressor by inhibiting tumor growth.MiR-205 is progressively down-regulated in lymph node metastasis but fails as a prognostic biomarker in high-risk prostate cancer.MicroRNAs as predictive biomarkers and therapeutic targets in prostate cancer.Silencing KRAS overexpression in arsenic-transformed prostate epithelial and stem cells partially mitigates malignant phenotype.Upregulation of miR-96 enhances cellular proliferation of prostate cancer cells through FOXO1MicroRNA profiling in prostate cancer--the diagnostic potential of urinary miR-205 and miR-214Tissue slide-based microRNA characterization of tumors: how detailed could diagnosis become for cancer medicine?Deregulation of MiR-34b/Sox2 Predicts Prostate Cancer Progression.The inhibitory effects of AR/miR-190a/YB-1 negative feedback loop on prostate cancer and underlying mechanism.Identification of miR-30b-3p and miR-30d-5p as direct regulators of androgen receptor signaling in prostate cancer by complementary functional microRNA library screening.MicroRNA Profiling in Patients with Upper Tract Urothelial Carcinoma Associated with Balkan Endemic NephropathymiR-375 and miR-205 Regulate the Invasion and Migration of Laryngeal Squamous Cell Carcinoma Synergistically via AKT-Mediated EMT.LncRNAs and miRNAs: potential biomarkers and therapeutic targets for prostate cancerEpigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy.MicroRNAs and drug resistance in prostate cancers.Nucleic acid-based tissue biomarkers of urologic malignancies.Functional significance of aberrantly expressed microRNAs in prostate cancer.Gene interference strategies as a new tool for the treatment of prostate cancer.Non-coding RNAs in Prostate Cancer: From Discovery to Clinical Applications.Prognostic and predictive miRNA biomarkers in bladder, kidney and prostate cancer: Where do we stand in biomarker development?The role of microRNAs in prostate cancer progression.Dissecting the role of microRNAs in prostate cancer metastasis: implications for the design of novel therapeutic approaches.MiR-205 functions as a tumor suppressor in adenocarcinoma and an oncogene in squamous cell carcinoma of esophagus.Deciphering the function of non-coding RNAs in prostate cancer.The roles of microRNAs in the progression of castration-resistant prostate cancer.miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis.Androgen receptor and miR-206 regulation in prostate cancer.The tumour suppressor miR-34c targets MET in prostate cancer cells.MicroRNA-205 Maintains T Cell Development following Stress by Regulating Forkhead Box N1 and Selected Chemokines.Targeting MicroRNAs in Prostate Cancer Radiotherapy.Significance of microRNAs in Androgen Signaling and Prostate Cancer Progression.Signal transducer and activator of transcription 3 regulates CCAAT-enhancer-binding homologous protein expression in osteoblasts through upregulation of microRNA-205.MicroRNA-205 functions as a tumor suppressor in colorectal cancer by targeting cAMP responsive element binding protein 1 (CREB1).
P2860
Q26770485-946E3EC1-3D83-47C0-84D9-23EE3CCC95ACQ26774456-90364CB9-F944-4EC3-9B2C-A2BF045A2551Q26795625-C92FACB3-E636-488F-A265-A8CA6FABC43CQ27014171-51A981B9-FA64-4EA4-936A-2D4329BB9352Q28084872-C96F3CDA-02FC-4501-A349-A665D6782509Q30859743-C7279874-61B8-4699-93FE-D698A7C3F7B8Q34176890-C0C34B98-4059-4E1E-A51D-21EA21E22919Q34366475-0E20A7DC-1732-4289-8C1D-718EF324DBA6Q34381328-AB21079C-3733-4F6F-ADAB-46BF6277541DQ34448246-7E6F3BBD-071F-4974-8C00-38306D6DD8D9Q34606029-8983BB72-98A7-4C51-AE4C-E555CFD9652DQ34951635-BBBD600F-A2FE-4E99-8BF1-A050811CE1DDQ35027675-EDDFA3D1-B64E-424B-92DB-ECD9DDA5EDCEQ35190111-B827D481-A8DD-498A-B1E5-21FC5762B14FQ35672901-622AA5B1-8348-4A6F-A40C-C804D8ACB640Q36002634-B2F9636F-5B73-443D-8BEB-9807577E5ED5Q36147506-F37F10F8-944F-45A6-ADD0-9429287333FAQ36889708-AEE06FF2-BD82-4DD5-9C9C-81FBDC76C718Q37548074-812776B3-F10E-42E1-BC37-060AE48BE5E6Q37553695-16656B3C-36A0-4516-BED6-AB8C91804839Q37629548-90EE7AAA-EF78-4928-834E-22A3E96A9E33Q38205266-C2FB1090-E865-4471-B708-E8DCBD97761BQ38216131-0A7A1FD6-8D09-44AF-BB8E-0B8D4AD2EF95Q38323461-D80AE54F-C201-4426-8403-4BD923D81D22Q38518046-D810605E-F241-4835-BAF2-DF5D3439FD32Q38667234-C20B26DA-3A62-4C54-B81C-D741F732068EQ38667456-8CECE800-C076-4097-9405-D44662786492Q38712604-4C323D2D-B712-47E8-9856-EE53EDB6594FQ38771880-DB26E239-E13A-422E-8281-87CCA2258982Q38808371-B4157143-B8D6-4A67-B63F-F304792546EFQ38843392-F0591068-98FA-422E-B8D4-D189563909F2Q38859577-27CF963C-673C-40EF-BBEF-60B97AD3F526Q38875539-DB1D5D6A-D8B0-4D21-8818-4318FA8300B0Q38946793-E2052CDD-1C32-4BCC-8A6B-5FAFF77F3367Q39114252-0001ED7A-9AEF-4AF3-A18E-0B1454A8DEF3Q40480062-EAA35518-A056-4E3A-9C56-3BFE99607CDCQ41239908-FD61D098-7093-4F5B-AB25-B07497035DA8Q41552623-CB93E593-4E8F-440C-9EDD-B36ADEE03E77Q41554003-5DC4D69C-52DF-4783-ACE9-39AFCF15E383Q41922910-848CF401-261D-4760-ADC4-435FC904624F
P2860
miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
miR-205 negatively regulates t ...... e of prostate cancer patients.
@en
miR-205 negatively regulates t ...... e of prostate cancer patients.
@nl
type
label
miR-205 negatively regulates t ...... e of prostate cancer patients.
@en
miR-205 negatively regulates t ...... e of prostate cancer patients.
@nl
prefLabel
miR-205 negatively regulates t ...... e of prostate cancer patients.
@en
miR-205 negatively regulates t ...... e of prostate cancer patients.
@nl
P2093
P2860
P356
P1476
miR-205 negatively regulates t ...... e of prostate cancer patients.
@en
P2093
A Bjartell
B S Haflidadóttir
P2860
P2888
P304
P356
10.1038/BJC.2013.131
P407
P50
P577
2013-04-09T00:00:00Z